Patent US4383035A successfully refreshed from Google Patents.
US4383035A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for the production of human luteinizing hormone
Assignee: Hayashibara Seibutsu Kagaku Kenkyujo KK
•
Filing: 1981-08-07
•
Granted: 1983-05-10
•
Expires: 2001-08-07
Abstract
Abstract The present invention relates to a process for the production of human luteinizing hormone (hLH). More precisely, the invention relates to a process for the mass production of hLH, comprising in vivo multiplication of human cells capable of producing hLH, using non-human warm-blooded animal, and exposure of the multiplied human cells to a luteinizing hormone inducer. The hLH production according to the invention is extremely higher, in terms of hLH production per cell, than that attained by conventional processes using in vitro tissue culture, thus, hLH can be used in a sufficient amount in the prevention and treatment of human diseases.
Inventors
- 👤 Kaname Sugimoto
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 20:20
CPC Classifications
C; C12; C12N; C12N15/00; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/59; C12P; C12P21/00; A; A61; A61K; A61K38/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
188 words
A process for producing human luteinizing hormone (hLH), which comprises: (1) implanting human cells capable of producing hLH into a non-human warm-blooded animal; feeding the animal to cause the human cells therein to multiply; extracting and disaggregating the resultant multiplied human cells formed in the animal; culturing the human cells in a nutrient medium in the presence of a luteinizing hormone inducer for a period sufficient to accumulate a significant amount of hLH; and harvesting the accumulated hLH from the culture, or alternatively, (2) placing human cells capable of producing hLH in suspension in a diffusion chamber; embedding the chamber in or placing the chamber on a non-human warm-blooded animal in a manner such that the nutrient body fluid of the non-human warm-blooded animal is supplied to the cells within the chamber; feeding the animal to cause the human cells in the chamber to multiply; collecting the multiplied human cells from the chamber; culturing the human cells in a nutrient medium in the presence of a luteinizing hormone inducer for a period sufficient to accumulate a significant amount of hLH; and harvesting the accumulated hLH from the culture.
Claim 2
Dependent Claim
188 words
A process for producing human luteinizing hormone (hLH), which comprises: (1) implanting human cells capable of producing hLH into a non-human warm-blooded animal; feeding the animal to cause the human cells therein to multiply; extracting and disaggregating the resultant multiplied human cells formed in the animal; culturing the human cells in a nutrient medium in the presence of a luteinizing hormone inducer for a period sufficient to accumulate a significant amount of hLH; and harvesting the accumulated hLH from the culture, or alternatively, (2) placing human cells capable of producing hLH in suspension in a diffusion chamber; embedding the chamber in or placing the chamber on a non-human warm-blooded animal in a manner such that the nutrient body fluid of the non-human warm-blooded animal is supplied to the cells within the chamber; feeding the animal to cause the human cells in the chamber to multiply; collecting the multiplied human cells from the chamber; culturing the human cells in a nutrient medium in the presence of a luteinizing hormone inducer for a period sufficient to accumulate a significant amount of hLH; and harvesting the accumulated hLH from the culture.
Claim 3
Dependent Claim
36 words
A process as set forth in claim 1, wherein said human cells capable of producing hLH are hybridoma cells derived by means of cell fusion of an established human lymphoblastoid line with human basophile adenoma cells.
Claim 4
Dependent Claim
20 words
A process as set forth in claim 2, wherein said established human lymphoblastoid line is a human leukemic lymphoblastoid line.
Claim 5
Dependent Claim
18 words
A process as set forth in claim 2, wherein said established human lymphoblastoid line is Namalwa or JBL.
Claim 6
Dependent Claim
22 words
A process as set forth in claim 2, wherein said hybridoma cells are derived by means of cell fusion using Sendai virus.
Claim 7
Dependent Claim
30 words
A process as set forth in claim 1, wherein said luteinizing hormone inducer is one or more members selected from the group consisting of amino acids, inorganic salts, and hormone.
Claim 8
Dependent Claim
19 words
A process as set forth in claim 1, wherein said non-human warm-blooded animal is a poultry or a mammalian.
Claim 9
Dependent Claim
43 words
A process as set forth in claim 1, wherein said luteinizing hormone inducer is one or more members selected from the group consisting of lysine, arginine, tryptophan, leucine, casamino acid, sodium chloride, potassium chloride, calcium chloride, magnesium sulfate, and luteinizing hormone releasing hormone.
Claim 10
Dependent Claim
33 words
A process as set forth in claim 1, wherein said non-human warmblooded animal is a chicken, pigeon, dog, cat, monkey, goat, pig, cow, horse, rabbit, guinea pig, rat, hamster, mouse or nude mouse.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-05-09 | 1986-11-08 | 1987-05-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-05-09 | 1990-11-08 | 1991-05-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-05-09 | 1994-11-08 | 1995-05-10 | $7700.00 | Window Closed / Lapsed |